Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery
for
Prostate Cancer,
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Sex: Male
Age: 18+
Code: NCT07188064
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: Montreal, Boston MA, New Haven CT, Toronto,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase1, Phase2, Recruiting
68Ga-DOTA-TATE PET/CT Imaging in NETs
for
Neuroendocrine Tumors
Location: Montreal, Sherbrooke
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Sex: All
Age: 0+
Code: NCT04847505
Phase3, Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Montreal, Greenfield Park, Burlington VT, Ottawa,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase2, Recruiting
Pulmonary Capillary Recruitment in Fontan Patients
for
Congenital Heart Disease
Location: Montreal
Sponsor: Jewish General Hospital
Sex: All
Age: 18 - 60
Code: NCT04292483
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
for
Lung Cancer
Location: Montreal
Sponsor: Lady Davis Institute
Sex: All
Age: 18+
Code: NCT02321293
Phase1, Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Montreal, Greenfield Park, Burlington VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis
for
Sclerosis, Systemic, Mesenchymal Stem Cells
Location: Montreal
Sponsor: Marie Hudson, MD
Sex: All
Age: 18+
Code: NCT04356287
Phase1, Phase2, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Montreal, Ottawa, Montvale NJ, Harrison NY, Toronto,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
for
Breast Cancer Surgery
Location: Montreal, Quebec, New Haven CT, Hamilton,
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Sex: Female
Age: 18 - 70+
Code: NCT06888388
Recruiting
AdVance® vs ARGUS® Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence
for
Stress Urinary Incontinence
Location: Montreal
Sponsor: Jewish General Hospital
Sex: Male
Age: 18+
Code: NCT01866085
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Montreal, Boston MA, Providence RI, Manhasset NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase3, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Montreal, Greenfield Park, Burlington VT, Ottawa,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma